Hospital support for fatty liver disease
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests whether extra hospital support helps people with fatty liver disease. It may help you learn how to manage your condition and improve your liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with fatty liver disease using an ultrasound or CT scan.
- You have mild to moderate liver scarring (fibrosis), as shown by a FibroScan or a blood test called FIB-4.
- You have not had a liver imaging test (like ultrasound or CT) in the last 5 years.
- You do not drink more than about 3-4 alcoholic drinks per week (50g for women, 70g for men).
- You are able to understand and follow the study procedures.
- You are not currently in another clinical trial that would interfere with this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication for people with fatty liver disease. It will see if the drug can reduce liver fat and improve liver health over several doses.
This study asks people with metabolic fatty liver disease and liver scarring about their experiences. It aims to learn what matters to you so doctors can improve care.
This study tests whether a specially designed gut bacteria treatment can help people with fatty liver disease and related health issues like high blood sugar, high cholesterol, or high blood pressure. It aims to see if the treatment is safe and improves liver health.
This study looks at how the liver's immune environment changes in people with non-alcoholic fatty liver disease (NAFLD) that has progressed to significant scarring. Researchers will use a liver biopsy to understand the inflammation better, which may lead to new treatments.
This trial tests whether taking probiotics plus making lifestyle changes can improve fatty liver and metabolic health. You may qualify if you have liver fat and at least one sign of metabolic problems like high blood sugar or high blood pressure.
This study tracks how liver scarring (fibrosis) and fat buildup (steatosis) change over time in people with nonalcoholic fatty liver disease (NAFLD). It helps doctors understand risk factors so they can better predict and manage the disease.
Hear when a new Hepatic Steatosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.